| 2709 |
389: Increased, Intracellular Calcium overload |
1477: Decrease, OXPHOS |
Jul 25, 2022 |
Jul 25, 2022 |
None
|
| 2710 |
389: Increased, Intracellular Calcium overload |
2017: Endoplasmic reticulum stress |
Jul 25, 2022 |
Jul 25, 2022 |
1 AOP
|
| 3042 |
389: Increased, Intracellular Calcium overload |
1816: Mitochondrial dysfunction EMPTY |
Sep 14, 2023 |
Sep 14, 2023 |
None
|
| 3091 |
389: Increased, Intracellular Calcium overload |
2078: Loss of drebrin |
Oct 18, 2023 |
Apr 4, 2025 |
1 AOP
|
| 3248 |
389: Increased, Intracellular Calcium overload |
1392: Oxidative Stress |
Jun 19, 2024 |
Jun 19, 2024 |
1 AOP
|
| 3256 |
389: Increased, Intracellular Calcium overload |
2151: Disruption, neurotransmitter release |
Jun 19, 2024 |
Jun 19, 2024 |
1 AOP
|
| 3426 |
389: Increased, Intracellular Calcium overload |
1532: Decrease, Cardiac contractility |
Nov 21, 2024 |
Nov 21, 2024 |
2 AOPs
|
| 1465 |
1322: Increased, intracellular chloride (Cl-) |
1356: Inactive, membrane depolarization |
Apr 14, 2017 |
Apr 14, 2017 |
1 AOP
|
| 1525 |
1398: Increased, intracellular serotonin |
1399: Increased, packaged serotonin |
Jun 1, 2017 |
Jun 1, 2017 |
3 AOPs
|
| 1455 |
1321: Increased, intracellular sodium (Na+) |
1352: Activated, voltage-gated sodium channel |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 3424 |
1321: Increased, intracellular sodium (Na+) |
2287: Impaired Sodium-Calcium Exchange |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|
| 2576 |
1196: Increased, Invasion |
1193: N/A, Breast Cancer |
Feb 15, 2022 |
Feb 15, 2022 |
None
|
| 3138 |
1196: Increased, Invasion |
1982: Metastasis, Breast Cancer |
Mar 5, 2024 |
Mar 5, 2024 |
1 AOP
|
| 2462 |
759: Increased, Kidney Failure |
350: Increase, Mortality |
Aug 5, 2021 |
Aug 5, 2021 |
None
|
| 2466 |
759: Increased, Kidney Failure |
351: Increased Mortality |
Aug 11, 2021 |
Aug 11, 2021 |
1 AOP
|
| 2627 |
1985: Increased, Kisspeptin signalling |
1986: Decreased, Gonadotropins |
Apr 5, 2022 |
Aug 15, 2022 |
1 AOP
|
| 1120 |
1081: Increased, lactotroph hyperplasia and hypertrophy |
1082: Increased, adenomas (pituitary) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1117 |
1080: Increased, latency period |
1079: Increased, Adenomas/carcinomas (mammary) |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 508 |
467: Increased, LDL uptake |
327: Accumulation, Fatty acid |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3443 |
467: Increased, LDL uptake |
1442: Foam cell formation |
Nov 25, 2024 |
Nov 25, 2024 |
1 AOP
|
| 1545 |
1411: Increased, leukocyte activation |
1385: Activated, gastric ulcer formation |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 1544 |
1410: Increased, leukocyte adherence |
1411: Increased, leukocyte activation |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 794 |
791: Increased, Leutinizing hormone (LH) |
744: Increase, Hyperplasia (Leydig cells) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1405 |
1306: Increased, lipogenesis |
1305: Increase, cytosolic fatty acid |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1695 |
459: Increased, Liver Steatosis |
1115: Increase, ROS |
Nov 14, 2017 |
Nov 14, 2017 |
1 AOP
|